We are live on ! Find out more
B

Braidwell Portfolio holdings

AUM $3B
1-Year Est. Return 46.72%
This Fund
S&P 500
This Quarter Est. Return
+4.4%
1 Year Est. Return
+46.72%
3 Year Est. Return
+56.07%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.06B
AUM Growth
+$28.4M
Cap. Flow
-$1.45B
Cap. Flow %
-47.27%
Top 10 Hldgs %
37.02%
Holding
99
New
15
Increased
19
Reduced
16
Closed
14

Top Buys

1
KROS icon
Keros Therapeutics
KROS
+$50.1M
2
BSX icon
Boston Scientific
BSX
+$37.5M
3
VRDN icon
Viridian Therapeutics
VRDN
+$30.9M
4
MRVI icon
Maravai LifeSciences
MRVI
+$24.4M
5
AXNX
Axonics, Inc. Common Stock
AXNX
+$21.7M

Top Sells

1
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$90.4M
2
GKOS icon
Glaukos
GKOS
+$43.8M
3
AMGN icon
Amgen
AMGN
+$39M
4
ISRG icon
Intuitive Surgical
ISRG
+$30M
5
BLU
BELLUS Health Inc.
BLU
+$29.7M

Sector Composition

1 Healthcare 54.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MLYS icon
51
Mineralys Therapeutics
MLYS
$2.41B
$9.38M 0.31%
550,300
– –
MRTX
52
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$8.69M 0.28%
240,625
-211,375
-47% -$8.71M
SGEN
53
DELISTED
Seagen Inc. Common Stock
SGEN
$8.18M 0.27%
+42,497
New +$8.44M
AGEN
54
Agenus
AGEN
$209M
$7.52M 0.25%
+234,897
New +$7.52M
NUVB icon
55
Nuvation Bio
NUVB
$2.05B
$7.42M 0.24%
4,122,900
– –
ADPT icon
56
Adaptive Biotechnologies
ADPT
$3.67B
$4.35M 0.14%
648,451
– –
ESPR
57
DELISTED
Esperion Therapeutics
ESPR
$1.25M 0.04%
895,949
-315,570
-26% -$441K
ATEC icon
58
Alphatec Holdings
ATEC
$1.39B
$457K 0.01%
+25,431
New +$396K
ACLX
59
DELISTED
Arcellx
ACLX
– –
-333,800
Closed -$10.3M
AMGN icon
60
Amgen
AMGN
$193B
– –
-161,500
Closed -$39M
ARGX icon
61
argenx
ARGX
$54B
– –
-24,600
Closed -$9.17M
AVTX icon
62
Avalo Therapeutics
AVTX
$975M
– –
-1,030
Closed -$433K
GMED icon
63
Globus Medical
GMED
$10.7B
– –
-335,200
Closed -$19M
IMTX icon
64
Immatics
IMTX
$1.29B
– –
-322,287
Closed -$2.22M
MRSN
65
DELISTED
Mersana Therapeutics
MRSN
– –
-134,232
Closed -$13.8M
PACB icon
66
Pacific Biosciences
PACB
$475M
– –
-1,097,300
Closed -$12.7M
SNDX icon
67
Syndax Pharmaceuticals
SNDX
$2.08B
– –
-920,049
Closed -$19.4M
STE icon
68
Steris
STE
$20.6B
– –
-95,694
Closed -$18.3M
TMDX icon
69
Transmedics
TMDX
$2.61B
– –
-98,459
Closed -$7.46M
SILK
70
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
– –
-63,331
Closed -$2.48M
ISEE
71
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
– –
-3,714,672
Closed -$90.4M
BLU
72
DELISTED
BELLUS Health Inc.
BLU
– –
-4,126,194
Closed -$29.7M
1 2
3

Similar funds

NC
NZS Capital Denver, Colorado $3B AUM 21.29% 1-Year Est. Return
VVP
Venture Visionary Partners Sylvania, Ohio $3B AUM 24.41% 1-Year Est. Return
SP
SurgoCap Partners New York $2.99B AUM 39.34% 1-Year Est. Return
DIG
Dragoneer Investment Group San Francisco, California $3B AUM 6.95% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3B AUM 34.24% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
ROTUOC
Regents of the University of California Oakland, California $3.01B AUM 11.91% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return